Fig. 2.
Percentages (mean ± SD of 4 patients) of CD38++ plasma cells expressing HLA-DR and HLA-DQ, CD40, and costimulatory molecules after incubation of BMMCs without (▪) or with the addition of IFN-γ (□), TNF-α (), or IL-6 (▨).
Percentages (mean ± SD of 4 patients) of CD38++ plasma cells expressing HLA-DR and HLA-DQ, CD40, and costimulatory molecules after incubation of BMMCs without (▪) or with the addition of IFN-γ (□), TNF-α (), or IL-6 (▨).
